Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment [2]

Journal of Neurology

Volumn 254, Issue 1, 2007, Pages 110-112

  Cannas, Antonino ^a   Solla, Paolo ^a   Floris, Gian Luca ^a   Serra, Giulia ^a   Tacconi, Paolo ^a   Marrosu, Maria Giovanna ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE;

ANAMNESIS; BEHAVIOR DISORDER; CLINICAL FEATURE; CONFUSION; DOPAMINERGIC SYSTEM; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXHIBITIONISM; FAMILY RELATION; FROTTEURISM; HALLUCINATION; HUMAN; INCEST; LETTER; LIBIDO DISORDER; MEDICAL RECORD; MOTOR DYSFUNCTION; OBSESSION; OBSESSIVE MASTURBATION; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PEDOPHILIA; PRESCRIPTION; PRIORITY JOURNAL; RAPE; RISK FACTOR; SEXUAL DEVIATION; SIDE EFFECT; ZOOPHILIA;

ADULT; AGED; DOPAMINE AGENTS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 33847137204     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0285-x     Document Type: Letter

References (14)

1. Berger Ch, Mehrhoff FW, Beier KM, Meinck HM (2003) Sexual delinquency and Parkinson's disease. Nervenarzt 74(4): 370-375
2. Cummings JL (1991) Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 39(7): 708-716
3. Fahn S, Elton RL, members of the UP-DRS Development Committee (1987) The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, et al. (eds). Recent developments in Parkinson's disease. Flotham Park, NJ: Macmillan Healthcare Information, pp 153-163
4. Fernandez HH, Durso R (1998) Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Mov Disord 13(3): 597-598
5. Folstein MF, Folstein SE, McHugh PR (1995) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198
6. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5): 427-442
7. Hughes AJ, Ben-Shlomo SE, Daniels SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease? Neurology 42: 1142-1146
8. Jimenez-Jimenez FJ, Sayed Y, Garcia-Soldevilla MA, Barcenilla B (2002) Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 36(7-8): 1178-1179
9. Jimenez-Jimenez FJ, Tallon-Barranco A, Cabrera-Valdivia F, Gasalla T, Orti-Pareja M, Zurdo M (1999) Fluctuating penile erection related with levodopa therapy. Neurology 52(1): 210
10. Quinn NP, Toone B, Lang AE, Marsden CD, Parkes JD (1983) Dopa dose-dependent sexual deviation. Br J Psychiatry 142: 296-298
11. Kanovsky P, Bares M, Pohanka M, Rektor I (2002) Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease. J Neurol 249(1): 112-114
12. Molina JA, Sainz-Artiga MJ, Fraile A, Jimenez-Jimenez FJ, Villanueva C, Orti-Pareja M, Bermejo F (2000) Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 15(5): 869-872
13. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9): 1136-1139
14. Riley DE (2002) Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline. Clin Neuropharmacol 25(4): 234-237